CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 115 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,689,359 | -29.9% | 1,809,261 | -12.4% | 0.01% | -35.7% |
| Q1 2023 | $10,971,395 | +68304.5% | 2,066,176 | -19.1% | 0.01% | -39.1% |
| Q4 2022 | $16,039 | -100.0% | 2,553,878 | -22.4% | 0.02% | -55.8% |
| Q3 2022 | $34,719,000 | +137.8% | 3,290,898 | +22.4% | 0.05% | +160.0% |
| Q2 2022 | $14,603,000 | -40.7% | 2,689,227 | +0.2% | 0.02% | -28.6% |
| Q1 2022 | $24,644,000 | -14.8% | 2,684,548 | +40.1% | 0.03% | -3.4% |
| Q4 2021 | $28,919,000 | -38.3% | 1,916,431 | -2.5% | 0.03% | -44.2% |
| Q3 2021 | $46,898,000 | – | 1,964,707 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 544,196 | $5,741,000 | 19.52% |
| Elmwood Wealth Management, Inc. | 2,364,240 | $24,943,000 | 12.45% |
| 72 Investment Holdings, LLC | 474,067 | $5,001,000 | 3.96% |
| PFM Health Sciences, LP | 6,000,000 | $63,300,000 | 2.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 257,892 | $2,716,000 | 0.87% |
| Avidity Partners Management LP | 3,172,600 | $33,471,000 | 0.68% |
| Green Alpha Advisors, LLC | 69,376 | $732,000 | 0.62% |
| Rokos Capital Management LLP | 1,907,509 | $20,811,000 | 0.62% |
| Nelson Capital Management, LLC | 85,020 | $897,000 | 0.26% |
| Tekla Capital Management LLC | 567,147 | $5,983,000 | 0.24% |